Viale, G., Slaets, L., de Snoo, F. A., Bogaerts, J., Russo, L., van’t Veer, L., . . . Cardoso, F. (2016). Discordant assessment of tumor biomarkers by histopathological and molecular assays in the EORTC randomized controlled 10041/BIG 03-04 MINDACT trial breast cancer: Intratumoral heterogeneity and DCIS or normal tissue components are unlikely to be the cause of discordance. Breast Cancer Res Treat.
Chicago Stili AlıntıViale, Giuseppe, et al. "Discordant Assessment of Tumor Biomarkers By Histopathological and Molecular Assays in the EORTC Randomized Controlled 10041/BIG 03-04 MINDACT Trial Breast Cancer: Intratumoral Heterogeneity and DCIS or Normal Tissue Components Are Unlikely to Be the Cause of Discordance." Breast Cancer Res Treat 2016.
MLA AlıntıViale, Giuseppe, et al. "Discordant Assessment of Tumor Biomarkers By Histopathological and Molecular Assays in the EORTC Randomized Controlled 10041/BIG 03-04 MINDACT Trial Breast Cancer: Intratumoral Heterogeneity and DCIS or Normal Tissue Components Are Unlikely to Be the Cause of Discordance." Breast Cancer Res Treat 2016.